Transfection Technologies Market is Expected to Reach $1.8 Billion | MarketsandMarkets™

Chicago, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Transfection Technologies market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Factors like increasing prevalence of chronic diseases, rising need of advanced therapies, and growing research activities in the field of cell biology are driving the growth of transfection technologies market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=895

Transfection Technologies Market Scope:

Report Coverage	Details
Market Revenue in 2023	$1.2 billion
Estimated Value by 2028	$1.8 billion
Growth Rate	Poised to grow at a CAGR of 9.4%
Market Size Available for	2021–2028
Forecast Period	2023–2028
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product Type, Method, Application, and End User
Geographies Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
Report Highlights	Updated financial information / product portfolio of players
Key Market Opportunity	Increased adoption of on body Transfection Technologies
Key Market Driver	High prevalence of diabetes

Technological advancements, particularly in the utilization of nanoparticles and 3D transfection methods, are reshaping the transfection landscape. Nanoparticles enable targeted and efficient delivery of genetic material, enhancing gene therapy and vaccine development. Meanwhile, 3D transfection techniques offer more physiologically relevant cell culture models for drug testing and disease research. These breakthroughs are poised to revolutionize biotechnology industries, driving innovation in drug discovery and personalized medicine, ultimately transforming the business landscape.

Based on product type, the transfection technologies market is segmented into kits & reagents and equipment. Kits & reagents accounted for the largest share of the global transfection technologies market in 2022. The large share of this segment can primarily be attributed to the increasing research activities in the field of cell biology. Additionally, rising need of superior quality of transfection reagents is anticipated to drive the segment growth.

Based on the method, the global transfection technologies market is segmented into physical transfection, biochemical based transfection, and viral vector-based transfection. In 2022, physical transfection accounted for the largest share of the transfection technologies market. The large share of this segment can be attributed to the high adoption of advanced transfection technologies owing to increasing demand for cell and gene therapy. The viral vector-based transfection segment is expected to record the highest CAGR during the forecast period. This can be attributed to the increasing focus on development of advanced therapies due to increasing prevalence of chronic and rare diseases.

Based on application, the transfection technologies market has been segmented into biomedical research, therapeutic delivery, protein production, and cell-based microarrays. In 2022, therapeutic delivery accounted for the largest market share because transfection technologies are widely used to introduce nucleic acids into cells for the treatment of chronic diseases. In addition, rising research practices to develop advanced therapeutics is propelling the segment growth in transfection technologies market.

Based on end user, the transfection technologies market has been segmented into pharmaceutical and biotechnology companies, CROs & CDMOs, academic and research institutes, and other end users. In 2022, pharmaceutical and biotechnology companies accounted for the largest share of the transfection technologies market. The large share of this segment can be attributed to the high adoption of transfection methods by pharmaceutical and biotechnology companies for cell and gene therapies. Technological advancements such as laserfection and 3D transfection also drive the adoption of transfection technologies by pharmaceutical and biotechnology companies.

The key regional markets for the global transfection technologies market are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the market. The large share of this region can be attributed to the increasing demand for cell and gene therapy and rising focus on advancement of healthcare infrastructure. However, most of the growth in the market is expected from emerging countries across Asia Pacific. During the forecast period, the Asia Pacific is expected to be the fastest-growing regional market. Factors such as the increasing research practices in the field of biotechnology and life sciences are driving growth in these markets. Moreover, growing focus on advancement of biopharmaceutical industry is boosting the growth of transfection technologies market in Asia Pacific region.

Buy a Transfection Technologies Industry Report (399 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=895

Transfection Technologies market major players covered in the report, such as:

• Thermo Fisher Scientific Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• QIAGEN (Netherlands)
• Merck KGaA (Germany)
• Sartorius AG (Polyplus) (Germany)
• Lonza (Switzerland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Agilent Technologies, Inc. (US)
• MaxCyte (US)
• Revvity (US)
• Takara Bio Inc. (Japan)
• Promega Corporation (US)
• Danaher Corporation (US)
• BOC Sciences (US)
• RJH BIOSCIENCES (Canada)
• Synvolux (Netherlands)
• Altogen Biosciences (US)
• BioIVT (US)
• Incella GmbH (Germany)
• InvivoGen (France)
• Phoreus Biotech (US)
• STEMCELL Technologies (Canada)
• EZ Biosystems (US)
• OZ Biosciences (France)
• chemicell GmbH (Germany)
• and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=895

This report categorizes the transfection technologies market into the following segments:

Transfection Technologies Market, by Product

• Kits & Reagents
• Equipment

Transfection Technologies Market, by Method

• Physical Transfection
  • Electroporation
  • Biolistic Technology/Gene Gun
  • Microinjection
  • Other Physical Transfection Methods
• Biochemical Based Transfection
  • Lipofection (Lipid-mediated Transfection)
  • Calcium Phosphate
  • Cationic Polymers
  • DEAE-Dextran
  • Magnet Assisted Transfection (MATra)
  • Dendrimer-Mediated Transfection
• Viral-Vector Based Transfection

Transfection Technologies Market, by Application

• Therapeutic Delivery
• Biomedical Research
• Protein Production
• Cell Based microarrays 

Transfection Technologies Market, by End User

• Pharmaceutical and Biotechnology Companies
• CROs & CDMOs
• Academic and Research Institutes
• Other End Users

Transfection Technologies Market, by region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest of Asia Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America (RoLATAM)
• Middle East & Africa
  • Middle East
    • GCC Countries
    • Rest of Middle East (RoME)
  • Africa

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=895

Key Market Stakeholders:

• Transfection products manufacturing companies
• Pharmaceutical & Biopharmaceutical Companies
• Chemical Companies
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Contract Development and Manufacturing Organizations (CDMOs)
• Research Institutes and Universities 
• Venture Capitalists & Investors
• Government Associations

Report Objectives:

• To define, describe, segment, and forecast the transfection technologies market by product type, method, application, end user, and region
• To provide detailed information about the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
• To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of the transfection technologies market in five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, along with their respective key countries
• To profile the key players in the transfection technologies market and comprehensively analyze their core competencies2 and market shares
• To track and analyze competitive developments, such as product launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the transfection technologies market
• To benchmark players within the transfection technologies market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share/rank

Related Reports:

Gene Editing Market

CRISPR Market

Genomics Market

Next Generation Sequencing Market

NGS Sample Preparation Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/transfection-technologies-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/transfection-technologies.asp

            About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com